Connect your AI

Merck & Co. MRK Operating Cash Flow

Operating Cash Flow at other companies

Bristol-Myers SquibbBMY

$1.1B-43.5%

PfizerPFE

$2.62B+12.0%

Johnson & JohnsonJNJ

$2.51B-39.8%

Regeneron PharmaceuticalsREGN

$1.08B+3.2%

CytokineticsCYTK

-$145.46M-10.5%

Phibro Animal HealthPAHC

$16.21M-62.4%

Other financials

Income statement

Revenue$16.3B+4.9%

Gross profit$12.1B-0.2%

Net income-$4.2B-183%

EPS (diluted)-$1.72-186%

Balance sheet

Cash & equivalents$5.4B-38.2%

Total debt$49.1B+35.8%

Total equity$45.9B-5.1%

Total assets$128.69B+11.8%

Cash flow

CapEx$991.0M-25.4%

Free cash flow$2.9B+150%

Valuation

Market cap$309.84B+56.1%

Enterprise value$353.54B+56.5%

P/E34.7×+23.3×

P/S4.7×+1.6×

Profitability

Gross margin73.9%-2.5pp

Net margin13.6%-13.7pp

FCF margin21.5%-5.2pp

Returns & leverage

Return on equity19%-20.3pp

Debt / equity1.1×+0.3×

Current ratio1.3×-0.1×

Where this comes from

Reported directly by Merck & Co. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Merck & Co.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merck & Co.'s operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Merck & Co.'s operating cash flow?: Merck & Co. (MRK) reported operating cash flow of $3.92B in Q1 2026.
How has Merck & Co.'s operating cash flow changed year-over-year?: Merck & Co.'s operating cash flow increased by 56.7% year-over-year, from $2.5B to $3.92B.
What is the long-term trend for Merck & Co.'s operating cash flow?: Over 4 years (2021 to 2025), Merck & Co.'s operating cash flow has grown at a 5.8% compound annual growth rate (CAGR), from $13.12B to $16.47B.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.